rs201794569
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016239.4(MYO15A):c.1387A>G(p.Met463Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,612,908 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00104 AC: 159AN: 152220Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00127 AC: 315AN: 248164Hom.: 1 AF XY: 0.00144 AC XY: 195AN XY: 135016
GnomAD4 exome AF: 0.00142 AC: 2076AN: 1460570Hom.: 3 Cov.: 36 AF XY: 0.00149 AC XY: 1086AN XY: 726582
GnomAD4 genome AF: 0.00105 AC: 160AN: 152338Hom.: 2 Cov.: 33 AF XY: 0.00101 AC XY: 75AN XY: 74482
ClinVar
Submissions by phenotype
not provided Benign:3
This variant is associated with the following publications: (PMID: 27375115, 30953472, 25262649, 22736430, 22903915, 30245029) -
MYO15A: BP4, BS2 -
- -
Autosomal recessive nonsyndromic hearing loss 3 Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
p.Met463Val in exon 2 of MYO15A: This variant is not expected to have clinical s ignificance because it has been identified in 0.3% (29/10144) Ashkenazi Jewish c hromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstit ute.org; dbSNP rs201794569). In addition, although this variant was previously reported in a family with hearing loss, it was in cis with a pathogenic loss of function variant that was the likely explanation of the hearing loss in that fam ily (Fattahi 2012). -
MYO15A-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at